Oral vs Intravenous Fluids – healthy volunteers

2024-519656-85-00 Protocol SVS.FAM.03 Human pharmacology (Phase I) - Other Ended

Start 18 Mar 2025 · End 1 May 2025 · Status Ended · 1 EU/EEA countries · 1 sites · Protocol SVS.FAM.03

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ended
Participants planned 20
Countries 1
Sites 1

Hemodynamic parameters is to be investigated -- comparing intravenous fluid therapy to oral fluid therapy

Key facts

Sponsor
Esbjerg Og Grindsted Sygehus
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Phenomena and Processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]
Trial duration
18 Mar 2025 → 1 May 2025
Decision date (initial)
2025-02-26
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Hemodynamic parameters is to be investigated -- comparing intravenous fluid therapy to oral fluid therapy

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Esbjerg Og Grindsted Sygehus

3 Total trials 2 Ended
Academic / Non-commercial
Sponsor organisation
Esbjerg Og Grindsted Sygehus
Address
Finsensgade 35
City
Esbjerg
Postcode
6700
Country
Denmark

Scientific contact point

Organisation
Esbjerg Og Grindsted Sygehus
Contact name
Peter Biesenbach

Public contact point

Organisation
Esbjerg Og Grindsted Sygehus
Contact name
Peter Biesenbach

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Denmark Ended 20 1
Rest of world 0

Investigational sites

Denmark

1 site · Ended
Esbjerg Og Grindsted Sygehus
Emergency Department, Finsensgade 35, 6700, Esbjerg

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Denmark 2025-03-18 2025-05-01 2025-03-18 2025-04-30

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-11-25 Denmark Acceptable
2025-02-26
2025-02-26